• SENSEX 77,414.92
    -191.51 (--0.25%)
  • BANKNIFTY 51,564.85
    -11.00 (--0.02%)
  • Hind.Aeronautics
    4,294.00 5,675.00(%)
  • Zomato Ltd
    200.50 146.85(%)
  • Aster DM Health.
    504.00 558.30(%)
  • Reliance Industr
    1,269.05 1,156.00(%)
  • Tata Motors
    684.90 1,179.05(%)
  • Jio Financial
    232.25 394.70(%)
  • Mazagon Dock
    2,635.55 920.48(%)
  • Vodafone Idea
    6.77 6.60(%)
  • HDFC Bank
    1,836.40 1,880.00(%)
  • Suzlon Energy
    56.40 37.95(%)
  • M & M
    2,635.10 1,872.45(%)
  • IDFC First Bank
    54.63 52.60(%)
  • Dixon Technolog.
    13,019.00 7,100.05(%)
  • I R F C
    123.65 108.05(%)
  • Bharat Electron
    306.50 340.35(%)
  • Adani Energy Sol
    863.60 588.25(%)
  • Asian Paints
    2,322.35 2,125.00(%)
  • Reliance Power
    44.75 54.25(%)
  • Hindustan Copper
    218.75 195.35(%)
  • IndusInd Bank
    643.70 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Gujarat Terce Laboratories Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 3500.0
  • ISIN : INE499G01013
61.14 0 (-0.59%)
  • As on 01 Apr 2025 (EOD)

  • Today’s Low

    60.80

  • Today’s High

    62.11

  • Open

    62.11

  • Perv Close

    61.50

  • 52W Low

    44.52

  • 52W High

    94.90

Key Indicators

  • P/E(TTM)

    15.36

  • Mar.Cap (₹Cr.)

    45.37

  • Div & Yield %

    0.00

  • Book Value(₹)

    11.94

  • Debt-Equity Ratio

    -0.59

  • AGM Date

    28-Mar-2025

  • EPS

    3.98

  • P/E Ratio

    15.36

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    45.37

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    7.42

  • BV (₹)

    11.90

  • Sales( ₹ in Cr.)

    47.97

  • NP (in Cr.)

    0.24

  • NP Var(%)

    115.0

  • Div%

    0.0

  • CPS (₹)

    0.80

  • EPS (₹)

    0.30

  • Traded Value (₹ in Lakhs)

    45.37

  • 52 Week High

    94.90

  • 52 Week Low

    44.52

  • Price BSE

    61.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    45.37

  • P/C Ratio

    74.10

  • P/E Ratio

    186.00

  • Price Vs.BV

    0.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 47.97 46.78 40.13 25.18 37.54 31.03
Excise Duty 47.97 46.78 40.13 25.18 37.47 30.89
Net Sales 47.97 46.78 40.13 25.18 37.54 31.03
Other Income 0.32 0.35 0.31 0.80 0.29 0.32
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 48.30 47.14 40.44 25.98 37.83 31.36
EXPENDITURE :
Raw Materials 47.97 46.78 40.13 25.18 37.47 30.89
Power & Fuel Cost 47.97 46.78 40.13 25.18 37.47 30.89
Employee Cost 15.78 14.73 15.83 12.97 15.13 12.82
Other Manufacturing Expenses 0.07 0.10 0.56 0.37 0.95 0.89
Selling & Administrative Expenses 12.78 14.21 5.63 3.59 5.70 3.85
Miscellaneous Expenses 0.07 0.10 0.56 0.37 0.95 0.89
Less : Pre-operative Expenses Capitalised :
Total Expenditure 47.75 50.03 39.69 28.51 37.39 31.01
Operating Profit 0.40 0.55 1.74 1.02 1.18 0.96
Interest 0.68 0.72 0.40 0.39 0.29 0.25
Gross Profit 0.54 -2.89 0.75 -2.53 0.44 0.35
Depreciation 0.37 0.36 0.28 0.18 0.24 0.21
Profit Before Tax 0.54 -2.89 0.75 -2.53 0.44 0.35
Tax 0.00 0.00 0.00 0.00 0.21 0.13
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.30 -1.22 -0.13 -0.01 -0.05 -0.22
Reported Net Profit 0.24 -1.67 0.87 -2.52 0.28 0.43
Extraordinary Items 0.54 -2.89 0.75 -2.53 0.44 0.35
Adjusted Net Profit 0.24 -1.67 0.87 -2.52 0.28 0.43
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 0.24 -1.67 0.87 -2.52 0.28 0.43
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.33 -2.25 1.18 -3.40 0.37 0.58
Book Value 0.00 0.00 0.00 0.00 0.00 0.00
Book Value(Adj)-Unit Curr 0.00 0.00 0.00 0.00 0.00 0.00

Shareholding Pattern

  • Promoter Group

    37.03%

  • Public Share Holding

    62.97%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 1,083,400 14.60 1,083,400 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,664,327 22.43 1,664,327 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 2,747,727 37.03 2,747,727 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 104,778 1.41 102,978 22
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 56,885 0.77 56,885 25
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,373,532 18.51 1,373,232 34
Individuals holding nominal share capital up to Rs. 1 lakh 3,036,893 40.93 1,861,893 13,537
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 100,485 1.35 100,485 86
Sub Total 4,672,573 62.97 3,495,473 13,704
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 7,420,300 100.00 6,243,200 13,710

Company Background

Gujarat Terce Laboratories LtdPharmaceuticals - Indian - Formulations

  • Gujarat Terce Laboratories Ltd
  • BSE Code : 3500.0
  • ISIN : INE499G01013

  • Incorporation Year

    1985

  • Registered Office

    122/2 Ravi Estate
    Bileshwarpura Chhatral, Gandhinagar,
    Gujarat-382729

  • Telephone

    91-079-6663 3706

  • FAX

  • Chairman

    Natwarbhai P Prajapati

  • Managing Director

    Aalap Prajapati

  • Company Secretary

  • Auditor

    M A Shah & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No 56-2 ,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Gujarat Terce Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Guj. Terce Labs. 61.14 48.30 47.97 15.36 7.17
Abbott India 30,730.65 6,097.18 5,848.91 48.94 44.71
Astrazeneca Phar 8,606.35 1,330.33 1,295.53 221.87 33.26
P & G Health Ltd 5,142.30 1,166.89 1,151.26 36.08 39.76
Glaxosmi. Pharma 2,877.30 3,530.73 3,407.25 57.21 44.44
Cipla 1,441.70 17,645.00 16,574.34 24.72 20.10
Amrutanjan Healt 644.85 437.58 421.23 37.80 20.84
Guj. Themis Bio. 281.50 174.19 169.82 58.28 44.82
Fermenta Biotec. 273.55 315.24 307.09 25.93 4.10
Bliss GVS Pharma 117.55 638.96 605.46 26.90 11.19
Ambalal Sarabhai 35.05 11.70 3.81 14.98 1.92